Deucravacitinib by Bristol-Myers Squibb can help with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and systemic lupus erythematosus.
Autoimmune Diseases
Posted inAutoimmune Diseases, Clinical Trials, Metabolism
Insulin Icodec: Basal Insulin Once a Week
Novo Nordisk will offer a very patient-friendly weekly version of insulin.
Posted inAutoimmune Diseases, Clinical Trials, In the Pipeline, New Drugs, Regulatory
Alopecia Areata Treatment: What Future Holds
What new drugs for hair loss are being developed by the pharmaceutical industry?
Posted inAutoimmune Diseases, New Drugs, Regulatory
Zoryve: New Effective Cream for Psoriasis
Roflumilast will cure plaque psoriasis in half of patients.
Posted inAutoimmune Diseases, New Drugs, Regulatory
Opzelura: New Treatment for Vitiligo
Ruxolitinib cream will help most patients treat nonsegmental vitiligo.
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience
Ublyxi: Highly Effective Drug for Multiple Sclerosis
Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory
Tepezza: First Drug for Thyroid Eye Disease
Teprotumumab by Horizon Therapeutics can really help with proptosis and diplopia in Graves’ disease and beyond.
